# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
201 | 232 Elman I, Borsook D, Lukas SENEUROPSYCHOPHARMACOLOGY. 2006 OCT; 31 (10): 2091-2120
| 0 | 24 | 11 | 499
|
202 | 252 Kalivas PW, Peters J, Knackstedt LMOLECULAR INTERVENTIONS. 2006 DEC; 6 (6): 339-344
| 6 | 24 | 6 | 42
|
203 | 299 Lang UE, Sander T, Lohoff FW, Hellweg R, Bajbouj M, et al.PSYCHOPHARMACOLOGY. 2007 MAR; 190 (4): 433-439
| 2 | 24 | 1 | 64
|
204 | 312 Bassareo V, De Luca MA, Di Chiara GPSYCHOPHARMACOLOGY. 2007 APR; 191 (3): 689-703
| 1 | 24 | 2 | 61
|
205 | 329 Stefano GB, Bianchi E, Guarna M, Fricchione GL, Zhu W, et al.MEDICAL SCIENCE MONITOR. 2007 JUN; 13 (6): RA91-RA102
| 1 | 24 | 5 | 197
|
206 | 341 Laviolette SRSCHIZOPHRENIA BULLETIN. 2007 JUL; 33 (4): 971-981
| 2 | 24 | 3 | 91
|
207 | 98 Janiri L, Martinotti G, Dario T, Reina D, Paparello F, et al.NEUROPSYCHOBIOLOGY. 2005; 52 (1): 37-44
| 5 | 23 | 1 | 55
|
208 | 124 Kamarajan C, Porjesz B, Jones KA, Chorlian DB, Padmanabhapillai A, et al.CLINICAL NEUROPHYSIOLOGY. 2005 MAY; 116 (5): 1049-1061
| 2 | 23 | 1 | 140
|
209 | 132 Sayers SL, Campbell EC, Kondrich J, Mann SC, Cornish J, et al.JOURNAL OF NERVOUS AND MENTAL DISEASE. 2005 JUN; 193 (6): 379-386
| 1 | 23 | 1 | 51
|
210 | 293 Benegal V, Antony G, Venkatasubramanian G, Jayakumar PNADDICTION BIOLOGY. 2007 MAR; 12 (1): 122-132
| 4 | 23 | 3 | 61
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
211 | 302 Goldstein RZ, Tomasi D, Alia-Klein N, Cottone LA, Zhang L, et al.DRUG AND ALCOHOL DEPENDENCE. 2007 MAR 16; 87 (2-3): 233-240
| 23 | 23 | 5 | 47
|
212 | 306 Franken IHA, van Strien JW, Franzek EJ, de Wetering BJVBIOLOGICAL PSYCHOLOGY. 2007 APR; 75 (1): 45-51
| 3 | 23 | 5 | 40
|
213 | 338 Yucel M, Lubman DI, Harrison BJ, Fornito A, Allen NB, et al.MOLECULAR PSYCHIATRY. 2007 JUL; 12 (7): 691-702
| 5 | 23 | 6 | 80
|
214 | 416 Rothman RB, Baumann MH, Prisinzano TE, Newman AHBIOCHEMICAL PHARMACOLOGY. 2008 JAN 1; 75 (1): 2-16
| 0 | 23 | 2 | 96
|
215 | 430 Clark DB, Thatcher DL, Tapert SFALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2008 MAR; 32 (3): 375-385
| 0 | 23 | 2 | 110
|
216 | 461 Cunha-Oliveira T, Rego AC, Oliueira CRBRAIN RESEARCH REVIEWS. 2008 JUN; 58 (1): 192-208
| 0 | 23 | 6 | 173
|
217 | 525 Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, et al.ARCHIVES OF NEUROLOGY. 2008 DEC; 65 (12): 1604-1611
| 1 | 23 | 3 | 34
|
218 | 594 Ko CH, Liu GC, Hsiao SM, Yen JY, Yang MJ, et al.JOURNAL OF PSYCHIATRIC RESEARCH. 2009 APR; 43 (7): 739-747
| 2 | 23 | 7 | 39
|
219 | 643 Stice E, Spoor S, Ng J, Zald DHPHYSIOLOGY & BEHAVIOR. 2009 JUL 14; 97 (5): 551-560
| 1 | 23 | 5 | 192
|
220 | 218 Koya E, Spijker S, Voorn P, Binnekade R, Schmidt ED, et al.JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (3): 905-915
| 4 | 22 | 7 | 55
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
221 | 231 Black YD, Maclaren FR, Naydenov AV, Carlezon WA, Baxter MG, et al.JOURNAL OF NEUROSCIENCE. 2006 SEP 20; 26 (38): 9656-9665
| 2 | 22 | 2 | 71
|
222 | 251 Rodriguez-Jimenez R, Avila C, Jimenez-Arriero MA, Ponce G, Monasor R, et al.JOURNAL OF GAMBLING STUDIES. 2006 DEC; 22 (4): 451-461
| 4 | 22 | 1 | 45
|
223 | 286 Pitel AL, Witkowski T, Vabret F, Guillery-Girard B, Desgranges B, et al.ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2007 FEB; 31 (2): 238-248
| 1 | 22 | 2 | 57
|
224 | 335 Pitel AL, Beaunieux H, Witkowski T, Vabret F, Guillery-Girard B, et al.ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2007 JUL; 31 (7): 1169-1178
| 5 | 22 | 4 | 78
|
225 | 346 Fowler JS, Alia-Klein N, Kriplani A, Logan J, Williams B, et al.BIOLOGICAL PSYCHIATRY. 2007 AUG 15; 62 (4): 355-358
| 7 | 22 | 0 | 26
|
226 | 374 Chung A, Lyoo IK, Kim SJ, Hwang J, Bae SC, et al.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2007 DEC; 10 (6): 765-775
| 5 | 22 | 2 | 37
|
227 | 412 Moghaddam B, Homayoun HNEUROPSYCHOPHARMACOLOGY. 2008 JAN; 33 (1): 42-55
| 3 | 22 | 12 | 154
|
228 | 460 Harris GJ, Jaffin SK, Hodge SM, Kennedy D, Caviness VS, et al.ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. 2008 JUN; 32 (6): 1001-1013
| 3 | 22 | 3 | 107
|
229 | 141 Muller DL, Unterwald EMJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2005 JUL; 314 (1): 148-154
| 1 | 21 | 1 | 40
|
230 | 197 Olmstead MCQUARTERLY JOURNAL OF EXPERIMENTAL PSYCHOLOGY. 2006 APR; 59 (4): 625-653
| 5 | 21 | 4 | 259
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
231 | 282 Verdejo-Garcia A, Rivas-Perez C, Vilar-Lopez R, Perez-Garcia MDRUG AND ALCOHOL DEPENDENCE. 2007 JAN 12; 86 (2-3): 139-146
| 8 | 21 | 4 | 55
|
232 | 327 Johnstone EC, Elliot KM, David SP, Murphy MFG, Walton RT, et al.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2007 JUN; 16 (6): 1065-1069
| 1 | 21 | 1 | 38
|
233 | 345 Pum M, Carey RJ, Huston JP, Muller CPPSYCHOPHARMACOLOGY. 2007 AUG; 193 (3): 375-390
| 3 | 21 | 6 | 91
|
234 | 361 Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, et al.BRAIN RESEARCH. 2007 SEP 26; 1171: 83-92
| 21 | 21 | 8 | 47
|
235 | 427 Munafo MR, Johnstone EC, Guo B, Murphy MFG, Aveyard PPHARMACOGENETICS AND GENOMICS. 2008 FEB; 18 (2): 121-128
| 0 | 21 | 2 | 47
|
236 | 579 Pelchat MLJOURNAL OF NUTRITION. 2009 MAR; 139 (3): 620-622
| 2 | 21 | 2 | 28
|
237 | 121 Bozikas VP, Kosmidis MH, Karavatos ASCHIZOPHRENIA RESEARCH. 2005 APR 1; 74 (1): 51-59
| 1 | 20 | 1 | 36
|
238 | 256 Dawkins L, Powell JH, West R, Powell J, Pickering APSYCHOPHARMACOLOGY. 2006 DEC; 189 (3): 355-367
| 3 | 20 | 6 | 52
|
239 | 370 Roberts DCS, Morgan D, Liu YPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2007 NOV 15; 31 (8): 1614-1624
| 2 | 20 | 4 | 79
|
240 | 10 Goldstein RZ, Volkow ND, Chang L, Wang GJ, Fowler JS, et al.NEUROREPORT. 2002 DEC 3; 13 (17): 2253-2257
| 18 | 19 | 2 | 18
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
241 | 12 Negrete JCCANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. 2003 FEB; 48 (1): 14-21
| 1 | 19 | 1 | 58
|
242 | 81 Kenna GA, McGeary JE, Swift RMAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2004 NOV 15; 61 (22): 2380-2388
| 2 | 19 | 1 | 109
|
243 | 202 White TL, Lott DC, de Wit HNEUROPSYCHOPHARMACOLOGY. 2006 MAY; 31 (5): 1064-1074
| 0 | 19 | 1 | 56
|
244 | 294 Szeszko PR, Robinson DG, Sevy S, Kumra S, Rupp CI, et al.BRITISH JOURNAL OF PSYCHIATRY. 2007 MAR; 190: 230-236
| 0 | 19 | 5 | 44
|
245 | 303 Baicy K, London EDADDICTION. 2007 APR; 102: 5-15
| 7 | 19 | 4 | 123
|
246 | 308 Franken IHA, Rassin E, Muris PJOURNAL OF AFFECTIVE DISORDERS. 2007 APR; 99 (1-3): 83-89
| 2 | 19 | 2 | 58
|
247 | 355 Ersche KD, Sahakian BJNEUROPSYCHOLOGY REVIEW. 2007 SEP; 17 (3): 317-336
| 10 | 19 | 17 | 248
|
248 | 366 Mandyam CD, Wee S, Eisch AJ, Richardson HN, Koob GFJOURNAL OF NEUROSCIENCE. 2007 OCT 17; 27 (42): 11442-11450
| 1 | 19 | 2 | 58
|
249 | 389 Haile CN, Kosten TA, Kosten TRAMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE. 2008; 34 (4): 355-381
| 1 | 19 | 6 | 175
|
250 | 456 Filbey FM, Claus E, Audette AR, Niculescu M, Banich MT, et al.NEUROPSYCHOPHARMACOLOGY. 2008 MAY; 33 (6): 1391-1401
| 5 | 19 | 7 | 68
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
251 | 491 George O, Mandyam CD, Wee S, Koob GFNEUROPSYCHOPHARMACOLOGY. 2008 SEP; 33 (10): 2474-2482
| 6 | 19 | 9 | 65
|
252 | 555 Tomasi D, Wang RL, Telang F, Boronikolas V, Jayne MC, et al.CEREBRAL CORTEX. 2009 JAN; 19 (1): 233-240
| 2 | 19 | 1 | 72
|
253 | 595 Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, et al.NEUROPSYCHOPHARMACOLOGY. 2009 APR; 34 (5): 1112-1122
| 19 | 19 | 13 | 95
|
254 | 97 Chen TJH, Blum K, Mathews D, Fisher L, Schnautz N, et al.MEDICAL HYPOTHESES. 2005; 65 (4): 703-707
| 2 | 18 | 2 | 29
|
255 | 138 Jorge RE, Starkstein SE, Arndt S, Moser D, Crespo-Facorro B, et al.ARCHIVES OF GENERAL PSYCHIATRY. 2005 JUL; 62 (7): 742-749
| 0 | 18 | 3 | 80
|
256 | 177 Orozco-Cabal L, Pollandt S, Liu J, Shinnick-Gallagher P, Gallagher JPREVIEWS IN THE NEUROSCIENCES. 2006; 17 (3): 279-307
| 0 | 18 | 3 | 224
|
257 | 196 Schlaepfer TE, Lancaster E, Heidbreder R, Strain EC, Kosel M, et al.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2006 APR; 9 (2): 147-153
| 3 | 18 | 4 | 51
|
258 | 205 Beveridge TJR, Smith HR, Daunais JB, Nader MA, Porrino LJEUROPEAN JOURNAL OF NEUROSCIENCE. 2006 JUN; 23 (11): 3109-3118
| 7 | 18 | 5 | 73
|
259 | 269 Winstanley CALINKING AFFECT TO ACTION: CRITICAL CONTRIBUTIONS OF THE ORBITOFRONTAL CORTEX. 2007; 1121: 639-655
| 5 | 18 | 7 | 72
|
260 | 300 Dawkins L, Powell JH, West R, Powell J, Pickering APSYCHOPHARMACOLOGY. 2007 MAR; 190 (4): 457-467
| 2 | 18 | 4 | 53
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
261 | 357 Hester R, Simoes-Franklin C, Garavan HNEUROPSYCHOPHARMACOLOGY. 2007 SEP; 32 (9): 1974-1984
| 12 | 18 | 5 | 83
|
262 | 379 Ary AW, Szumlinski KKBRAIN RESEARCH. 2007 DEC 12; 1184: 295-305
| 2 | 18 | 8 | 96
|
263 | 445 David SP, Munafo MR, Murphy MFG, Proctor M, Walton RT, et al.PHARMACOGENOMICS JOURNAL. 2008 APR; 8 (2): 122-128
| 0 | 18 | 1 | 66
|
264 | 513 Garavan H, Kaufman JN, Hester RPHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES. 2008 OCT 12; 363 (1507): 3267-3276
| 14 | 18 | 11 | 80
|
265 | 519 Briand LA, Flagel SB, Garcia-Fuster MJ, Watson SJ, Akil H, et al.NEUROPSYCHOPHARMACOLOGY. 2008 NOV; 33 (12): 2969-2980
| 7 | 18 | 6 | 55
|
266 | 583 Siep N, Roefs A, Roebroeck A, Havermans R, Bonte ML, et al.BEHAVIOURAL BRAIN RESEARCH. 2009 MAR 2; 198 (1): 149-158
| 1 | 18 | 3 | 84
|
267 | 593 Nelson CL, Milovanovic M, Wetter JB, Ford KA, Wolf MEJOURNAL OF NEUROCHEMISTRY. 2009 APR; 109 (1): 35-51
| 4 | 18 | 7 | 93
|
268 | 598 Andersen SL, Teicher MHNEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2009 APR; 33 (4): 516-524
| 1 | 18 | 5 | 174
|
269 | 658 Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, et al.BIOLOGICAL PSYCHIATRY. 2009 AUG 1; 66 (3): 287-292
| 0 | 18 | 1 | 49
|
270 | 61 Czoty PW, Morgan D, Shannon EE, Gage HD, Nader MAPSYCHOPHARMACOLOGY. 2004 JUL; 174 (3): 381-388
| 1 | 17 | 1 | 54
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
271 | 102 Goldstein RZ, Alia-Klein N, Leskovjan AC, Fowler JS, Wang GJ, et al.PSYCHIATRY RESEARCH-NEUROIMAGING. 2005 JAN 30; 138 (1): 13-22
| 17 | 17 | 4 | 33
|
272 | 207 Anderson CM, Maas LC, Frederick BD, Bendor JT, Spencer TJ, et al.NEUROPSYCHOPHARMACOLOGY. 2006 JUN; 31 (6): 1318-1326
| 3 | 17 | 2 | 76
|
273 | 245 Nogueira L, Kalivas PW, Lavin AJOURNAL OF NEUROSCIENCE. 2006 NOV 22; 26 (47): 12308-12313
| 7 | 17 | 3 | 36
|
274 | 305 Marshall JF, Belcher AM, Feinstein EM, O'Dell SJADDICTION. 2007 APR; 102: 61-69
| 0 | 17 | 2 | 63
|
275 | 330 Noel X, Van der Linden M, d'Acremont M, Bechara A, Dan B, et al.PSYCHOPHARMACOLOGY. 2007 JUN; 192 (2): 291-298
| 9 | 17 | 6 | 40
|
276 | 353 Mizoguchi H, Yamada K, Mouri A, Niwa M, Mizuno T, et al.JOURNAL OF NEUROCHEMISTRY. 2007 SEP; 102 (5): 1548-1560
| 2 | 17 | 2 | 46
|
277 | 373 Yucel M, Lubman DI, Solowij N, Brewer WJAUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 2007 DEC; 41 (12): 957-968
| 4 | 17 | 11 | 142
|
278 | 463 Laucht M, Becker K, Frank J, Schmidt MH, Esser G, et al.JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2008 JUN; 47 (6): 673-681
| 0 | 17 | 1 | 47
|
279 | 500 Seo DJ, Patrick CJ, Kennealy PJAGGRESSION AND VIOLENT BEHAVIOR. 2008 OCT; 13 (5): 383-395
| 1 | 17 | 2 | 149
|
280 | 505 Kalivas PWNEUROTOXICITY RESEARCH. 2008 OCT; 14 (2-3): 185-189
| 5 | 17 | 5 | 28
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
281 | 523 Blum K, Chen ALC, Chen TJH, Braverman ER, Reinking J, et al.THEORETICAL BIOLOGY AND MEDICAL MODELLING. 2008 NOV 12; 5: Art. No. 24
| 3 | 17 | 1 | 75
|
282 | 581 de Ruiter MB, Veltman DJ, Goudriaan AE, Oosterlaan J, Sjoerds Z, et al.NEUROPSYCHOPHARMACOLOGY. 2009 MAR; 34 (4): 1027-1038
| 5 | 17 | 13 | 66
|
283 | 70 Powell JH, Pickering AD, Dawkins L, West R, Powell JFADDICTIVE BEHAVIORS. 2004 SEP; 29 (7): 1407-1426
| 3 | 16 | 2 | 56
|
284 | 101 Czoty PW, McCabe C, Nader MAJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2005 JAN; 312 (1): 96-102
| 0 | 16 | 2 | 39
|
285 | 104 Lingford-Hughes ACURRENT OPINION IN PHARMACOLOGY. 2005 FEB; 5 (1): 42-46
| 4 | 16 | 5 | 38
|
286 | 130 Ziolkowska B, Gieryk A, Bilecki W, Wawrzczak-Bargiela A, Wedzony K, et al.JOURNAL OF NEUROSCIENCE. 2005 MAY 18; 25 (20): 4996-5003
| 0 | 16 | 1 | 52
|
287 | 199 Chang L, Haning WCURRENT OPINION IN PSYCHIATRY. 2006 MAY; 19 (3): 246-252
| 5 | 16 | 5 | 50
|
288 | 343 Matsumoto I, Alexander-Kaufman K, Iwazaki T, Kashem MA, Matsuda-Matsumoto HEXPERT REVIEW OF PROTEOMICS. 2007 AUG; 4 (4): 539-552
| 1 | 16 | 4 | 134
|
289 | 436 Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, et al.NEUROPSYCHOPHARMACOLOGY. 2008 MAR; 33 (4): 827-836
| 9 | 16 | 5 | 82
|
290 | 503 Gullo MJ, Dawe SNEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2008 OCT; 32 (8): 1507-1518
| 3 | 16 | 4 | 127
|
# | Date / Author / Journal | LCS | GCS | LCR | CR
|
---|
291 | 514 DaSilva AF, Becerra L, Pendse G, Chizh B, Tully S, et al.PLOS ONE. 2008 OCT 16; 3 (10): Art. No. e3396
| 0 | 16 | 1 | 86
|
292 | 532 Brewer JA, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MNBIOLOGICAL PSYCHIATRY. 2008 DEC 1; 64 (11): 998-1004
| 6 | 16 | 3 | 41
|
293 | 628 Dalley JW, Everitt BJSEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 2009 JUN; 20 (4): 403-410
| 5 | 16 | 13 | 131
|
294 | 7 Spinella MADDICTION BIOLOGY. 2002 OCT; 7 (4): 381-384
| 5 | 15 | 1 | 28
|
295 | 44 Bradberry CW, Rubino SRNEUROPSYCHOPHARMACOLOGY. 2004 APR; 29 (4): 676-685
| 8 | 15 | 1 | 69
|
296 | 229 Kindlundh-Hogberg AMS, Svenningsson P, Schioth HBNEUROPHARMACOLOGY. 2006 SEP; 51 (4): 838-847
| 1 | 15 | 1 | 78
|
297 | 406 Ryding E, Lindstrom M, Traskman-Bendz LSEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE. 2008; 172: 307-315
| 0 | 15 | 1 | 109
|
298 | 415 Goudriaan AE, Oosterlaan J, De Beurs E, Van Den Brink WPSYCHOLOGICAL MEDICINE. 2008 JAN; 38 (1): 41-50
| 5 | 15 | 8 | 75
|
299 | 426 Zhu W, Esch T, Kream RM, Stefano GBNEUROENDOCRINOLOGY LETTERS. 2008 FEB; 29 (1): 63-66
| 0 | 15 | 4 | 75
|
300 | 468 Bennett DS, Bendersky M, Lewis MDEVELOPMENTAL PSYCHOLOGY. 2008 JUL; 44 (4): 919-928
| 0 | 15 | 1 | 81
|